Invesco Ltd. Avidity Biosciences, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 310,356 shares of RNA stock, worth $13.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

310,356

Previous 350,355 11.42%

Holding current value

$13.5 Million

Previous $14.3 Million 0.41%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$37.21 - $48.14 $1.49 Million - $1.93 Million	-39,999 Reduced 11.42%	310,356 $14.3 Million
Q2 2024 Aug 13, 2024	SELL	$22.73 - $40.85 $521,903 - $937,956	-22,961 Reduced 6.15%	350,355 $14.3 Million
Q1 2024 May 14, 2024	BUY	$9.16 - $25.52 $2.25 Million - $6.26 Million	245,444 Added 191.95%	373,316 $9.53 Million
Q4 2023 Feb 12, 2024	SELL	$4.87 - $9.37 $49,323 - $94,899	-10,128 Reduced 7.34%	127,872 $1.16 Million
Q3 2023 Nov 13, 2023	BUY	$6.3 - $11.35 $281,313 - $506,811	44,653 Added 47.84%	138,000 $880,000
Q2 2023 Aug 11, 2023	SELL	$10.62 - $17.34 $779,890 - $1.27 Million	-73,436 Reduced 44.03%	93,347 $1.04 Million
Q1 2023 May 12, 2023	BUY	$15.35 - $25.65 $1.5 Million - $2.51 Million	97,862 Added 141.99%	166,783 $2.56 Million
Q4 2022 Feb 13, 2023	SELL	$10.06 - $22.66 $791,269 - $1.78 Million	-78,655 Reduced 53.3%	68,921 $1.53 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $1.74 Million - $2.64 Million	112,540 Added 321.21%	147,576 $2.41 Million
Q2 2022 Aug 15, 2022	BUY	$11.18 - $20.5 $53,652 - $98,379	4,799 Added 15.87%	35,036 $509,000
Q1 2022 May 16, 2022	BUY	$14.2 - $23.78 $219,276 - $367,210	15,442 Added 104.37%	30,237 $558,000
Q4 2021 Feb 14, 2022	BUY	$20.4 - $28.66 $10,873 - $15,275	533 Added 3.74%	14,795 $351,000
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $53,862 - $74,772	2,966 Added 26.26%	14,262 $352,000
Q2 2021 Aug 17, 2021	BUY	$19.62 - $29.26 $221,627 - $330,520	11,296 New	11,296 $279,000

Others Institutions Holding RNA

# of Institutions

256

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.28B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account